Mabylon AG
PrivateLast Round
VC Round
Aug 12, 2025
Total Funding Raised
$1.48M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Mabylon AG is a biotechnology company that discovers and develops human-derived antibody therapeutics for the treatment of allergies, inflammation, and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mabylon AG Comparables
Compare Mabylon AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IgGenix | 85% | |
| Dualitas Therapeutics | 78% | |
| Poplar Therapeutics | 77% |
Mabylon AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 12, 2025 | ||||
| Grant | Sep 24, 2024 |
Key People
Founding team and executive leadership
Mabylon AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The ALS Association | Grant |
| NIH RADx | Grant |
| Eurostars SME programme | Grant |
| Target ALS | Grant |
| Innosuisse | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Monthly visitors increased 151% MoM.
- Apr 21, 2026
Monthly visitors grew 217% MoM, reaching 606.
Mabylon AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mabylon AG's valuation, stock price, and market status.
Is Mabylon AG a public or private company?
Mabylon AG is a private company.
What is the current stock price of Mabylon AG?
Mabylon AG is a private company with no public stock price. No recent secondary market data is available.
How much is Mabylon AG worth (valuation)?
Valuation information for Mabylon AG is not publicly available.
Can I buy Mabylon AG stock?
Mabylon AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Mabylon AG's last funding round?
Mabylon AG's most recent funding round was VC Round on August 12, 2025.
Who are the main investors in Mabylon AG?
Key investors in Mabylon AG include The ALS Association, NIH RADx, Eurostars SME programme, Target ALS, Innosuisse.
Will Mabylon AG IPO soon?
No public IPO plans have been announced for Mabylon AG.
How can I track Mabylon AG secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mabylon AG's secondary market activity and sign up for updates.